CERA

Close Menu

Donate

Donate to CERA

Subscribe

Get monthly updates

Clinical trials

Take part in research
Close Close
Hope in sight TM

Our research is bringing hope to people affected by vision loss and blindness

Donate Now

Events

Community Forum and Mini Vision Expo 2024
Please join us on 4 October 2024 to celebrate the launch of our Consumer Advisory Group and discover how your involvement can influence the future of eye research.

Science and Research

Using gene therapy to reduce the need for eye injections
Learn how CERA’s next generation gene therapy research could transform the treatment of eye diseases including age-related macular degeneration and diabetic eye disease.

Stories

Annual Review: People in focus
The 2023 Annual Review People in focus celebrates everyone who helps CERA deliver innovative vision research that has real-life impact.

Celebrating Cerulea Clinical Trials

Cerulea Clinical Trials, CERA’s new not-for-profit clinical trials centre, is up and running.
Learn how Cerulea will transform the delivery of ophthalmic clinical trials, increase community access to sight-saving therapies and deliver excellence for clinicians, trial participants and sponsors.

Read more

Take part in research

Help shape the future of vision research by taking part in a clinical study.
Find out how you can take part in studies at CERA and Cerulea Clinical Trials for eye conditions including age-related macular degeneration, corneal conditions, diabetic retinopathy, glaucoma and inherited retinal disease.

Learn more

Latest News

The end of genetic discrimination in insurance

13 September 2024

New Australian Government policy removes barriers to genetic testing – encouraging early diagnosis and participation in clinical trials that could transform the future of personalised medicine and gene therapy for eye diseases.
News

Protecting sight to protect the mind

08 August 2024

A new report has named vision loss as a risk factor that could be modified to reduce the chance of developing dementia.
News

Leadership role for IRD innovator

08 August 2024

Associate Professor Lauren Ayton, a co-leader of CERA’s Retinal Gene Therapy Research Unit and VENTURE Study, has been appointed to the organisation’s executive team.
Research

AI scan for diabetes has potential to save sight and money

11 July 2024

Modelling shows AI-powered screening for diabetic retinopathy has the potential to prevent blindness by increasing access to scans, protecting sight and reducing healthcare costs.

Eye-news emails are sent to subscribers once a month

Newsletter Subscribe
Receive Appeals